Positive data from chronic scrotal content pain trial
Thalassaemia treatment gets EU approval
New data from Parkinson’s disease trial
Restoring the “longevity protein”
CAGE Bio collaborating to advance treatments for cutaneous graft versus host disease
D3 Bio gets KRAS G12C-mutated cancers boost
Raina Biosciences unveils generative AI platform for mRNA therapeutics
Menin: A new target for bladder cancer
Hongene to supply exNA oligonucleotide technology under new licensing deal
Collaboration to advance multi-omics innovation in South Korea
IQVIA and Flagship Pioneering to collaborate on developing breakthrough life sciences companies
FDA approves early Alzheimer’s disease treatment